The aim of this proposal is to provide new insights into cancer associated genotypic and phenotypic alterations and to provide novel tools and new markers potentially suitable for the screening, diagnosis, therapy, monitoring and prognostic evaluation of human malignancies. The strategy used therefore is the systematic identification and comprenhensive analysis of genes and gene products with a verified cancer related immunogenecity designated as the Cancer Immunome. To ensure the fast dissemination of information, the data obtained by these studies will be used to build up a comprehensive public database of the Cancer Immunome easily accessible for scientists from different fields via the internet.
Funding SchemeCSC - Cost-sharing contracts
SM2 5NG Sutton
NG7 6LB Nottingham
EH1 1HN Edinburgh